Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-598-4377Fax+1 206-598-4732
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1994
Certifications & Licensure
- WA State Medical License 1997 - 2025
- IL State Medical License 2000 - 2002
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Asacol Dosing Study for Active Ulcerative Colitis Start of enrollment: 2003 Jun 01
- Induction of Clinical Response Using Rifaximin in Crohn's Disease Start of enrollment: 2008 Nov 01
- Study of Cimzia for the Treatment of Ulcerative Colitis Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 study.Scott D Lee, Severine Vermeire, Ryan Ungaro, Aisha Vadhariya, Frederick Durand
The American Journal of Gastroenterology. 2025-03-13 - Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis.Scott D Lee, Adam C Ehrlich, Paola Pellanda, Christopher Kaiser, Kristin Todd
The American Journal of Gastroenterology. 2025-03-12 - Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure.Scott David Lee, Kendra J Kamp, Jeffrey Jacobs, Jason Harper, Mitra Barahimi
Journal of Clinical Gastroenterology. 2025-03-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: